RxDoctor Payments Data

Katlyn Langebrake, NP

Nurse Practitioner · Jasper, INNPI 1982314340

Payments from drug & device makers

$2,752in general payments, 2019–2025

Across 158 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$351
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$282
  • Takeda Pharmaceuticals U.S.A., Inc.$256
  • Ardelyx, Inc.$183
  • Madrigal Pharmaceuticals$171
  • plus $385 from 10 others

What the payments were for

  • Food & beverage$2,752100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,752 in reported general payments places this provider in the 85th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$141,807
Medicare patients
448
Services billed
4,354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$70,614
CreonLipase/Protease/Amylase18$48,310
LinzessLinaclotide65$43,591
MotegrityPrucalopride Succinate20$10,759
Dexlansoprazole DrDexlansoprazole25$4,406
Pantoprazole Sodium181$3,164
Ondansetron Hcl19$1,871
Sucralfate15$1,791
Colestipol Hcl16$1,273
Famotidine112$1,119
Esomeprazole Magnesium14$726
Omeprazole89$710
Dicyclomine Hcl32$448
Ondansetron OdtOndansetron12$356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,124$91,90183 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$256$10,75920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Jasper

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →